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Endovasuclar neurosurgery, neuroendovascular surgery and  neurointervention 
are all defined as endovascular diagnosis and treatment of vascular lesions involv-
ing the brain and spinal cord using catheters in the DSA (digital subtraction 
angiography) unite. Based on literature evidences, the field of endovascular neu-
rosurgery has evolved rapidly and successfully over the past half century and has 
resulted in effective endovascular therapies for carotid-cavernous fistulas (CCFs), 
intracranial aneurysms, arteriovenous malformations (AVMs), dural arteriovenous 
fistulas, atherosclerosis of cerebral arteries, acute stroke, carotid artery disease, and 
vascular tumors of the head, neck, and spinal vascular malformations and tumors. 
The scope of practice of neurovascular endovascular surgery has become complex, 
requiring training in specific skill sets and techniques. The evolution of the neuro-
endovascular field has resulted in the development of program requirements for 
residency or fellowship education in endovascular neurosurgery.
Keywords: cerebral aneurysm, arteriovenous malformation, stroke,  
endovascular technique
1. Background
Endovascular neurosurgery is now the most commonly practiced therapeutic 
approach for most vascular lesions involving the brain and spinal cord [1]. At the 
beginning, balloons are the only available techniques; latter coils, embolic agents, 
and stents are introduced [2]. With expansion of the endovascular devices and tech-
niques, the treatment strategies for cerebrospinal vascular diseases has been refined 
[3]. Neurosurgeons must have the mindset to embrace and nurture the progress 
and technologic advances. The pioneers of endovascular neurosurgery considered 
the impossible and tenaciously stood by their dreams [4]. Their revolutionary ideas 
and inventions truly reflected their courage, faith, and determination. The shift 
away from open surgical approaches has had far-reaching implications for how we 
train neurosurgical residents and fellows and how we certify these individuals once 
their training is completed [5]. With the maturity of endovascular neurosurgery 
technology, we need to re-examine the resident and fellow training for neurovas-
cular surgery. This chapter traces the evolution of endovascular neurosurgery and 





Endovascular neurosurgery is based on cerebral angiography. It is well known 
that Portuguese neurologist Antonio Egas Moniz, the recipient of the Nobel Prize 
in Physiology and Medicine in 1949, developed and described cerebral angiography 
firstly in 1927 [6]. Before using cadaveric specimens of human to develop the tech-
nique, he had successfully obtained cerebral angiograms in dogs. His first cerebral 
angiography was performed in a 48-year-old patient with Parkinson’s disease. The 
internal carotid artery (ICA) was ligated temporarily for 2 minutes and a 70% 
solution of strontium bromide was injected into the ICA at a dose of 13 to 14 ml. 
The middle and posterior cerebral arteries were demonstrated on his first film. 
Unfortunately, the patient died from thrombophlebitis 8 hours later. This invention 
ushered in the age of diagnostic and therapeutic angiography.
Cerebral angiography had a prominent role in defining neurosurgery as a spe-
cialty distinct from surgery. The cerebral angiography is based on X-ray imaging [7]. 
Contrast injection plus X-ray exposure combined with mask subtraction generates 
images of high resolution of the cerebral vasculature. In early angiogram systems, cut 
film and film cassettes were used, which required a technologist to exchange multiple 
cassettes to obtain series and angiography “runs”. At that time, angiography generated 
radiopaque images of the cerebral vasculature and could be used to identify vessel 
occlusions and eventually identify vascular lesions [8]. Distortion and displacement 
of the vascular anatomy could be used for hematoma or tumor localization.
There has been an ongoing evolution of the cerebral angiography, first as a 
diagnostic tool but then the potential for intervening in vascular pathology became 
possible. Subsequently, the eventual introduction of braided catheters and hydro-
philic wires, which allowed quick and safe catheterizations, set the foundation for 
intervention. Modern digital subtraction angiography (DSA) machines consist of an 
image intensifier and digital subtraction flat panel detectors that utilize a fraction of 
the radiation dosage for the acquisition of images of the finest detail [9]. The ability 
to rotate the image intensifier around the patient allowed the development of 3D 
rotational images [10].
Although cerebral angiography remains a mainstay in the diagnosis and endo-
vascular treatment of cerebrospinal vascular disorders [11], several limitations of 
this technique are evident. X-ray based cerebral angiography cannot view neuro-
vascular structures clearly in complex vascular lesions, lack resolution necessary 
to visualize small vessels and critical perforating vessels, which are essential to the 
treatment of many cerebrovascular disorders. As a real-time guide during therapy, 
intraluminal imaging with ultrasonography, maybe a resolution in the future. This 
technique will provide not only therapeutic guidance but also real-time documenta-
tion of the completeness of therapy.
3. Cerebral aneurysms
Endovascular treatment of cerebral aneurysms had its start in neurosurgery. 
Werner et al. firstly reported successful electrothermic thrombosis of an intra-
cranial aneurysm in 1941 [12]. With a transorbital puncture, “thirty feet of No. 34 
gauge coin silver enameled wire was introduced into the aneurysm through a special 
needle” and “the wire was heated to an average temperature of 80°C for a total of 40 
seconds. The aneurysm no longer bled when the needle was cleared at the conclu-
sion of the operation” [12].
After these early attempts, particularly in the 1960s and early 1970s, several neu-
rosurgeons and neuroradiologists sought therapeutic alternatives to conventional 
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surgery [2]. Lacking devices suitable for safe navigation in the intracranial vas-
culature, their efforts originally concentrated on the extravascular route. Under 
radiographic guidance, thrombosis was initiated by passing electrical current to 
an electrode needle introduced within the aneurysm sac through a burr hole [13]. 
Mullan et al. described the treatment of intracranial aneurysms in a series of 12 
patients, 10 of whom had presented with aneurysmal subarachnoid hemorrhage, by 
inducing electrothrombosis [13].
Until 1964, Luessenhop and Velasquez made the first endovascular attempt to 
treat a cerebral aneurysm [14]. They attempt to occlude a supraclinoid aneurysm with 
a silicone balloon. Subsequently, Serbinenko developed a balloon-mounted micro-
catheter with flow-directional capabilities for more effective intracranial catheteriza-
tion [15]. He further developed detachable and nondetachable balloon catheters to 
make parent artery sacrifice or direct aneurysmal obliteration and to allow temporary 
balloon occlusion safe and reliable in the 1970s. His contributions gave birth to 
endovascular neurosurgery [15]. Balloon occlusion techniques were further used with 
a vast amount of clinical experience during the 1970s and 1980s [16–18].
Several major limitations of balloon occlusion technique are apparent. 
Aneurysmal catheterization was difficult without help of guidewire. The balloon 
shape often could not adequately filling an irregular aneurysm with leaving the fun-
dus unprotected or creating a ball-valve effect of aneurysmal refilling. Therefore, 
the endovascular therapy of cerebral aneurysms shifted from balloon occlusion 
to free (pushable) platinum coil occlusion [2]. At this time, coil embolization for 
cerebral aneurysms is a dangerous procedure because of the inability to retrieve the 
pushed coils that migrated into the distal intracranial vasculature.
The innovation of electrolytic detachable coils by the Italian neurosurgeon 
Guido Guglielmi in the early 1990s updated the endovascular treatment of cerebral 
aneurysms [19, 20]. In the early 1980s, Guglielmi found accidental electrolytic 
detachment of the electrode tip while applying current to a stainless steel electrode 
inserted into an experimental aneurysm to promote electrothrombosis. After sev-
eral years, he worked with Ivan Sepetka, an engineer at Target Therapeutics, Inc., 
to combine the two processes of endovascular electrolysis and electrothrombosis, 
which eventually resulted in the development of the present-day Guglielmi detach-
able coil (GDC; Boston Scientific/Target Therapeutics, Fremont CA) [21]. The 
Guglielmi detachable coil (GDC) can be re-positioned and examined before the coil 
was released electrolytically from its tether. On the other hand, the flexibility and 
softness of the coil enabled the safe filling of an irregular aneurysm with a low risk 
of rupture. The first intracranial aneurysm was treated using this new technology 
on April 12, 1990 [19]. The first multicenter GDC clinical trial result was published 
by Guglielmi et al. in 1992 [20]. Immediate complete occlusion was obtained in 81% 
of small-necked and 15% of wide-necked aneurysms with low procedure-related 
morbidity and mortality rates less than 5%. The GDC system was immediately 
accepted worldwide and became the focus of most published works on cerebral 
aneurysm management (Figure 1).
Despite the advantages of the GDC system, wide-necked and large aneurysms 
remained difficult to treat. New techniques were performed to keep the detached 
coils within the aneurysmal sac. Moret et al. was the pioneer of the “remodeling 
technique” using a balloon as a mechanical barrier to keep coils within the aneurys-
mal sac during its delivery (Figure 2) [22]. Moret et al. [22] published their results 
with use of the “balloon-remodeling technique” for the treatment of 56 cases of 
previously untreatable wide-necked cerebral aneurysms in 1997 with low morbidity 
and mortality rates.
An alternative approach to introduce a stent to maintain a patent lumen and 
provid a buttress to prevent coil herniation. After some early attempts of Wakhloo 
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et al. [23] and Geremia et al. [24], this stent-assisting technique has been  
further explored and expanded by an increasing number of neurosurgeons [25]. 
Neurosurgeons and neurointerventional radiologists at several centers began to 
borrow stents from the interventional cardiology at the same time and publish their 
case reports about treating wide-necked aneurysms with a combination of stents 
and coils (Figure 3). These stents were designed specifically for cardiac usage and 
were stiffer and more difficult to use in the tortuous neurovascular anatomy.
With the introduction of neurovascular stents, specifically designed for intra-
cranial use (Neuroform stent, Boston Scientific Target), borrowing cardiac stents 
soon became unnecessary [26]. Although the use of stents required a regimen of 
Figure 1. 
A 46-year-old woman with a ruptured anterior communicating artery aneurysm was coiled with GDCs 
(Boston Scientific, USA) in 1998. A, frontal view of the left internal carotid artery injection. B, lateral view 
of the left internal carotid artery injection. Showing the aneurysm of the left anterior communicating artery 
(arrows). C, frontal view of the roadmap image of the left internal carotid artery injection showing the 
aneurysm (arrow). D, frontal view of the roadmap image after aneurysm coiling showing the disappearance 
of the aneurysm (arrow). E, frontal view of the left internal carotid artery injection after aneurysm coil 
embolization. F, lateral view of the left internal carotid artery injection after aneurysm coil embolization. 
Showing the aneurysm was completely occluded (arrows).
5
The History and Development of Endovascular Neurosurgery
DOI: http://dx.doi.org/10.5772/intechopen.97139
Figure 2. 
A 37-year-old man presented with subarachnoid hemorrhage. A, frontal view of the left vertebral artery 
injection showing a basilar tip aneurysm (arrow). B, roadmap of the left vertebral artery injection showing 
the first orbit 3-D 7 mm × 13 cm coil and a 4 mm × 20 mm Hyperglide balloon catheter (Medtronic ev3, 
USA) (arrow). C, the left vertebral artery injection showing the aneurysm was completely occluded after 
subsequent coils (Microplex 6 mm × 15 cm，6 mm × 10 cm，5 mm × 10 cm，orbit 5 mm × 15 cm，HydroCiol 
3 mm × 7 cm，2 mm × 4 cm，helix standard fiber 2 mm × 4 cm).
Figure 3. 
A vertebral artery aneurysm treated with coronary artery stent and coiling in 1990s. A, 3-D angiogram of the 
right vertebral artery injection showing a dissecting aneurysm of vertebral artery-inferior posterior cerebellar 
artery (arrow). B, angiogram of the right vertebral artery injection showing a microwire was passed through 
the aneurysm for navigation of a BX coronary artery stent (Medtronic, USA). C, angiogram of the right 
vertebral artery injection showing the aneurysm was coiled with assistance of a 3.0 mm × 18 mm BX coronary 
artery stent (Medtronic, USA)(arrow). D, angiogram of the right vertebral artery injection showing the 
aneurysm was completely occluded (arrow).
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antiplatelet medication adding to the risk of the procedure itself as well as risks 
associated with the recovery period, these risks were quickly accommodated by 
interventionalists and improved overall occlusion rates as decreased the aneurysm 
recurrence (Figure 4) [27].
Bioactive coils were explored by some manufacturers to promote thrombus 
formation and endothelialization. However, these modified coils were shown to 
have limited efficacy and no clear advantage over pure platinum coils when used 
alone [28]. The use of polymers was also explored by some authors to treat cerebral 
aneurysms, but the increased risk and patient morbidity derailed this strategy and 
prevented its widespread acceptance [29].
It was firstly confirmed by the International Subarachnoid Aneurysm Trial 
(ISAT) that more and more aneurysm patients were being treated worldwide with 
the introduction of detachable coils and various intracranial stents [30]. An overall 
decreased risk of death and morbidity in the endovascular group treated with 
detachable coils when compared to those treated with open surgery were found [30]. 
The worldwide treatment of both ruptured and unruptured aneurysms by detach-
able coils quickly has surpassed open surgery as the primary treatment modality. 
Covered stents already are used successfully in the treatment of cerebral aneurysms, 
iatrogenic pseudoaneurysms, and carotid-cavernous fistulas (CCF) [31, 32].
4. Flow diverter
The introduction of flow diverter had a dramatic effect on the management of 
cerebral aneurysms. The concept of flow diverter was initially explored by Wakhloo 
in 2014, but Nelson and colleagues developed the first commercially available flow 
diverter [33]. Flow diverter introduced the concept of a more physiological therapy 
for aneurysms, focusing on treating the parent vessel without the requirement of 
entering the aneurysm dome [34]. With data that indicated complete occlusion rates 
that approached 90% at follow-up in systematic review, treatment recommendations 
for selected intracranial aneurysms was made [35]. Even giant aneurysms, in the past 
managed with balloon test occlusion and vessel sacrifice or complex bypasses, can now 
be managed with flow diverter with great efficacy and considerably lower morbidity 
[36, 37] (Figure 5). Moreover, the indications for flow diversion have been extended to 
smaller aneurysms that are usually treated with coiling, stent-coiling, or clipping [38]. 
Figure 4. 
A 62-year-old woman presented with an incidental paraclinoid aneurysm of the internal carotid artery. A, 3-D 
reconstruction of the right internal carotid artery injection showing the 6 mm × 6 mm paraclinoid aneurysm 
of the internal carotid artery (arrow), which was treated with 4 mm × 30 mm Neuroform stent and coils. B, 
the unsubtracted image showing the Neuroform stent (black arrow) and the first 3-D coil (white arrow). C, 
oblique view of the right internal carotid artery injection after treatment showing the aneurysm was occluded 
completely (arrow).
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Cerebral aneurysms, both ruptured and unruptured, can be treated with flow divert-
ers [3]. Research into surface modification of devices to mitigate or negate the need 
for anticoagulation or antiplatelet medications is actively being pursued [3]. However, 
careful must be always taken in evaluating benefits and risks. In a recent paper by 
Gory et al., a total of 21.8% of interventions experienced at least 1 morbidity during 
the 12-month follow-up [39]. Among the serious events, 5.9% were considered perma-
nent and related to the procedure. Moreover sixty-six (16%) of the 412 interventions 
had a complication, and 10 of them caused a neurological deficit [40].
5. Carotid-cavernous fistulas
Carotid-cavernous fistulas (CCF) are usually treated endovascularly by 
interventional neuroradiologists or neurosurgeons. The endovascular treatment 
strategies of CCF has dramatically changed with the evolution of endovascular 
neurosurgery. A series of treatment modalities have been traditionally attempted, 
including the carotid artery ligation or trapping, muscle embolization via cervical 
exposure of the carotid artery, and balloon embolization with or without carotid 
artery sacrifice [41]. Brooks reported successful closure of a CCF with a muscle 
embolus introduced surgically into the carotid artery in 1930 [42]. Serbinenko revo-
lutionized the therapy for CCF in the 1970s by introducing detachable intravascular 
balloons [43]. Though these lesions were often treated with balloon test occlusion 
and vessel sacrifice in the early stage (Figure 6), CCFs are now almost exclusively 
treated by an endovascular strategy with preservation of the internal carotid artery. 
Balloon embolization of CCF through a transfemoral access with preservation of 
the distal ICA has reduced the morbidity related to the treatment. This method is 
the primary therapy in most cases of CCF [44]. In addition to the balloon emboliza-
tion, several other modalities have been deemed useful in the treatment of CCF in 
recent years [45], such as detachable coils, covered stents, ethylene vinyl alcohol 
copolymer (EVOH) and flow diverter placement [45, 46] (Figure 7). Transvenous 
embolization via the inferior petrosal sinus, superior ophthalmic vein and EVOH 
embolization modalities have been used with success [46]. Spontaneous resolution 
and/or thrombosis of CCF has also been reported, especially in indirect CCF, but 
Figure 5. 
A 58-year-old woman presented with visual deficit caused by a giant supraclinoid aneurysm of the internal 
carotid artery, which was treated by flow diverter. a, right internal carotid artery (ICA) angiogram 
(anteroposterior) demonstrating a giant aneurysm of the supraclinoid internal carotid artery. b, right ICA 
angiogram (anteroposterior) after pipeline flex flow diverter and coil embolization showing nearly complete 
occlusion of the aneurysm. c, right ICA angiogram (anteroposterior) at 1-year follow-up showing complete 
occlusion of the aneurysm.
Neurosurgery
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it is really rare. For less directly accessible lesions, superior ophthalmic vein access 
or direct puncture of the cavernous sinus and catheterization as an alternative 
approach to the cavernous sinus as well as transvenous routes can all be used [47].
Figure 6. 
A 50-year-old male patient of carotid-cavernous fistula was treated with detachable balloon in 1985. A, 
right internal carotid artery (ICA) angiogram (anteroposterior) and lateral (B) showing a direct carotid 
cavernous fistula and early opacification of right cavernous sinus with no antegrade flow beyond the cavernous 
sinus. C, left vertebral artery angiogram (lateral) showing opacification of right cavernous sinus. Because 
the patient had no neurological symptoms with no contribution from the right ICA, no balloon test occlusion 
was performed before sacrifice of the ICA. D, fluoroscopic view of the head (anteroposterior) and lateral (E) 
showing the placement of one detachable balloon in the ICA of fistula site. F, left vertebral artery angiogram 
confirming complete occlusion of the fistula with reconstitution of the distal ICA blood flow from the vertebral 
artery. No retrograde filling of the fistula is seen.
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6. Arteriovenous malformation
Exponential advances in catheter technology and refinements of embolic 
agents have greatly facilitated the rapid evolution of AVM embolization. In 1960’s, 
Luessenhop and Spence performed the first embolization procedure on a cerebral 
AVM by surgically introducing silastic spheres made of methyl methacrylate into 
the ICA [48]. At that time, silk sutures, porcelain beads, Gelfoam, steel balls, 
Teflon-coated spheres, and polyvinyl alcohol were explored for AVM emboliza-
tion with varying degrees of efficacy [49]. The use of these particle emboli was 
associated with a high complication rate secondary to inadvertent embolization of 
a normal cerebral vessel because the technologies and devices were not for direct 
nidus embolization.
Kerber developed the first calibrated-leak balloon, which allowed the direct 
embolization of an AVM nidus with the use of a rapidly solidifying polymer in 
Figure 7. 
A 33-year-old male patient of traumatic carotid-cavernous fistula was treated with preservation of the 
internal carotid artery. A, lateral view of the right external carotid artery showed an arteriovenous shunt 
between the anterior meningeal branch of the middle meningeal artery and the right superior ophthalmic 
vein (arrowhead). B, lateral view of the right carotid artery showed the high-flow carotid-cavernous fistula 
drained by the right superior ophthalmic vein and the right inferior petrosal sinus (arrow). C lateral view of 
unsubtracted image showed the inflated scepter C balloon (4 mm × 20 mm, Microvention, USA) in the right 
internal carotid artery (arrow) and the coils. Note the external carotid artery fistula was occluded with coils 
(arrowhead). D, lateral view of the left carotid artery angiogram after balloon-assisted onyx injection showed 
complete obliteration of the both fistulas and the intact left internal carotid artery.
Neurosurgery
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1976 [50]. This new system in combination with advances in imaging techniques 
and liquid embolic materials ushered in the modern era of AVM embolization. 
However, the use of calibrated-leak balloon catheters was associated with a high 
risk of arterial rupture. The introduction of liquid embolic agents, initially in 
the form of n-BCA, an acrylic adhesive [51], and advances in microcatheter and 
microwire design facilitated the distal catheterization of vascular malformations 
so that embolization of AVMs has evolved immensely over the last few decades to 
become a highly valuable therapy, and even an alternative in some cases, to surgery 
or stereotactic radiosurgery [52, 53]. The introduction of polymer non-adhesives 
(EVOH) allowed deep and extensive nidal penetration without the need for repeat 
distal catheterization and could be performed over long embolization procedure 
time periods [52].
Cerebral angiography detailed morphology study of the arteriovenous mal-
formation involves evaluating the hemodynamic and anatomic characteristics of 
the lesion, including examination of the feeding arteries, the nidus itself, venous 
drainage of the lesion, coexisting aneurysms and arteriovenous fistulas [54]. A 
variety of strategies emerged, including multiple pedicle embolizations of the 
nidus. This was used by Lv et al. to “embolize AVM for cure” with low morbidity 
and mortality [55] (Figures 8 and 9). Endovascular surgery has specific indica-
tions in the treatment of AVMs, such as ruptured AVM, AVM of small size or deep 
locations, AVM with coexisting aneurysm and high flow fistula. Theoretically 
discussed and considered in the past, transvenous embolization is now being 
extensively explored, but its initial reports documented higher procedure-related 
hemorrhage rates [56].
Figure 8. 
A 40-year-old male patient presented brain stem hemorrhage caused by a small arteriovenous malformation. 
Anteroposterior angiography views (A-D) and lateral angiography views (E-H) . Showing a posterior pons 
arteriovenous malformation (AVM) fed by the left perforating artery of the basilar trunk (arrows in panels 
of a, E). Superselective angiogram demonstrating the ectasia of draining vein (arrows in panels of B, F). 
Angiograms after superselective onyx embolization showing complete disappearance of the AVM (arrows in 
panels of C, G). Postoperative images demonstrating onyx cast (arrows in panels of D, H).
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7. Vein of Galen malformations
Vein of Galen malformations are extremely rare lesions occurring in one out 
of a million live births [57]. They are treated almost exclusively with endovascular 
surgery. The lesions are amenable to endovascular embolization in the newborn pre-
senting with heart failure or diagnosed in utero. An initial treatment stage is neces-
sary and followed by additional staged embolization when the child is large enough 
to undergo more extensive embolization. Embolization strategies include closing the 
individual arteriovenous shunts or the initial venous side of the malformation.
8. Dural arteriovenous fistulas
Dural arteriovenous fistulas (DAVFs) represent a specific vascular lesion that 
incorporates the dural suppliers of the cranium or spine, contributing direct arte-
rial shunting toward venous structures. Venous hypertension can lead to cortical 
Figure 9. 
A 5-year-old boy presented with intracranial hemorrhage caused by a small arteriovenous malformation.  
a, anteroposterior angiography of the left vertebral artery showing a small arteriovenous malformation 
(AVM) fed by the left posterior cerebral artery. b, anteroposterior angiography of the left vertebral artery 
after superselective onyx embolization showing complete disappearance of the AVM.
Figure 10. 
A dural fistula fed by pial branches of the frontobasal artery was cured with onyx emblization. A, later 
internal carotid artery (ICA) angiogram showing a dural fistula fed by pial branches of the frontobasal artery 
and early opacification of frontal polar vein (arrowhead). Note the pseudoaneurysm on the feeding artery 
(arrow). B, superselective angiography by the microcatheter showing the pseudoaneurysm (arrow) and the 
fistula point (arrowhead). C, lateral internal carotid artery angiogram confirming complete occlusion of the 
aneurysm and the dural fistula.
Neurosurgery
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dysfunction, venous hypertension, and hemorrhage when DAVF occurs intracrani-
ally [58]. However, dilation of venous structures along the spinal cord can lead to 
myelopathy from tissue engorgement and venous hypertension as well as physical 
compression when DAVF occurs in the spine. The complex anatomy and points of 
arteriovenous shunting make their management complex. EVOH-based embolic 
materials have been proved to be useful in the endovascular obliteration of these 
lesions [59] (Figure 10). When these materials are combined with balloon cath-
eters, a deep penetration to the point of arteriovenous shunts can be achieved [60]. 
Transvenous approaches are also routinely employed and highly successful when 
arterial access to the fistula point cannot be achieved (Figure 11) [61].
9. Spinal vascular malformations
Vascular lesions of the spine and spinal cord can be categorized into intra-
medullary and extramedullary lesions [62]. These lesions are rare and comprise a 
heterogeneous spectrum of diseases. They were first reported in the 19th century 
with the autopsy-based classification of Virchow and Picard [63]. However, it was in 
the 1970s, with the advent of selective spinal angiography, that they became better 
understood [64]. Their identification and localization have progressed signifi-
cantly with the development of imaging techniques [65]. Several classification 
systems have been proposed over time to describe vascular lesions of the spine [66].  
Figure 11. 
A cavernous sinus dural fistula was cured with tranvenous access. a, lateral view of the left carotid artery 
showed the left indirect carotid-cavernous fistula drained by the left superior ophthalmic vein and the left 
inferior petrosal sinus was invisible. b, under roadmap image, the left inferior petrosal sinus was catheterized. 
c, under roadmap image, coils were delivered through the microcatheter in the left cavernous sinus through the 
left inferior petrosal sinus. d, frontal view of the left carotid artery showed complete obliteration of the carotid-
cavernous fistula and the intact left internal carotid artery.
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Figure 12. 
A 49-year-old man presented weakness of two legs. a, left T-8 intercostal pedicle injection reveals the anterior 
spinal artery from above and below along the axis to supply the perimedullary fistula. b, under roadmap 
image a microcatheter was accessed to the fistulous point. c, control angiogram after onyx embolization reveals 
obliteration of the fistula with preservation of the anterior spinal axis.
Figure 13. 
A 37-year-old woman presented with SAH caused by a juvenile type spinal AVM. A, the right subclavian 
angiogram. B, aortic artery angiogram. Reveal supply to the AVM in the vertebra and the soft tissue around 
with feeders arising from right subclavian and intercostal arteries. After treatment, aortic artery angiogram 
(C) and the right subclavian angiogram (D), partial embolization with coils to reduce the venous congestion 
was performed through the left radiculomedullary artery (arrow).
Neurosurgery
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The well known classification proposed by Anson and Spetzler in 1992 is type 
I, dural arteriovenous fistula (AVF); type II, glomus intramedullary AVM 
(Figure 12); type III, juvenile malformations (Figure 13); and type IV, perimedul-
lary AVF [67]. With recent advances in embolic materials and devices in endovascu-
lar treatment, transarterial embolization plays an increasingly important role in the 
treatment of spinal AVMs. Complete angiographical obliteration of the nidus is not 
necessarily the goal of embolization, but rather, the treatment aims to reduce shunt-
ing volume and stabilize the symptoms [68].
10. Venous sinus stenting
Transvenous approaches have become quite useful in the treatment of dural 
sinus stenosis, often associated with a diverticulum of the sinus [69, 70]. With 
venous sinus stenting, promising results have been achieved in treating intracranial 
hypertension and venous stenosis–related pulsatile tinnitus. King et al. (1995) 
were the first to describe the venous stenosis through venography and manometry 
in intracranial hypertension but Higgins et al. became the first to stent the venous 
sinus in 2002 on a female with medically refractory intracranial hypertension [71]. 
Venography revealed bilateral transverse sinus stenosis and after stenting of one 
side, there was a significant improvement in trans-stenosis gradient and symptom-
atic control. Only in severe cases of cerebral sinus thrombosis that do not improve 
or deteriorate despite anticoagulant therapy, endovascular treatment would be 
considered.
11. Cerebral atherosclerotic stenoses
The development of angioplasty and stenting was influenced by the early 
work of endoluminal dilation of peripheral atherosclerotic disease. Until 1980, 
cerebral transluminal balloon catheter dilatation was reported to treat two 
patients with frequent, severe, progressive symptoms despite anticoagulation and 
high-grade intracranial atherosclerotic stenosis (ICAS) of the basilar artery [72]. 
The excellent angiographic and short-term clinical in these two patients and the 
prevalence of ICAS had favored further research of this approach. Unfortunately, 
frequent complications were reported in the next case series, including arte-
rial dissection with consecutive thrombosis or rupture, residual stenosis due to 
sequestration or vessel recoiling and acute or subacute vascular occlusion due 
to the formation of a wall hematoma [72]. In order to reduce periprocedural 
complications of angioplasty alone, the rigid coronary Palmaz-Schatz stent was 
introduced for the first time in 1996 in a patient with recurrent TIA caused by 
severe ICAS of the right carotid artery despite antiplatelet and anticoagulant 
therapy [73]. The stent deployment led to a better angiographic result compared 
to angioplasty alone.
The first self-expanding, nitinol-composed Wingspan stent (Boston Scientific, 
Fremont, CA, USA) was approved by the US Food and Drug Administration (FDA) 
for patients with 50% or higher ICAS, symptomatic despite medical therapy in 2005 
[74]. These patients might benefit from endovascular therapy since their plaques 
might not stabilize with best medical therapy alone and cause recurrent artery-to-
artery embolic strokes. The development of new angioplasty balloon catheters and 
flexible stents has redefined the management strategy for symptomatic intracranial 
stenosis. A growing number of studies have reported a low complication profile and 
satisfactory rates of angiographic patency at follow-up [75].
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Figure 14. 
A 79-year-old man presented with dizziness. a, CT perfusion image showing the low perfusion of the right 
cerebral hemisphere. b, right carotid artery angiogram showing the severe stenosis of the internal carotid artery. 
c, right carotid artery angiogram showing the stenosis was treated with angioplasty and stenting.
Figure 15. 
A 64-year-old man presented with transient ischemic attack. A, left internal carotid artery (ICA) angiogram 
(anteroposterior) showing a severe stenosis of the M1 segment of the middle cerebral artery (arrow). B, under 
roadmap image showing a XT27 catheter (Stryker, USA) was advanced to the distal middle cerebral artery 
after balloon angioplasty (arrow). C, left internal carotid artery angiogram confirming the reconstitution of 




Angioplasty with stenting of carotid stenosis does not require general anesthesia 
and requires only a few seconds of carotid artery occlusion. Endoluminal revas-
cularization has been proposed for the treatment of carotid stenosis in high-risk 
patients such as those with contralateral carotid occlusion [76], postendarterectomy 
stenosis [77], and/or severe coronary and other systemic diseases [78]. In a meta-
analysis by Texakalidis et al. in 2018 including 13 comparative studies, compared 
to carotid artery endarterectomy carotid artery stenting had a lower incidence of 
cranial nerve injury, the two treatment approaches were similarly safe in terms of 
periprocedural stroke, myocardial infarction and death rates and carotid artery 
stent was associated with decreased restenosis risk (defined as either 60% or 70% 
stenosis) in the follow-up; however, without a significant difference in the risk of 
target lesion revascularization [79].
At present, we suggest that endovascular therapy may be considered as a treat-
ment option for patients with recurrent ischaemic stroke despite best medical 
therapy and especially if pathophysiologically attributed to hypoperfusion with/
without bad collaterals [80] (Figures 14 and 15). In future, better experience of 
interventionalists and improved features of stents deployed are also expected to 
boost outcome of endovascular therapy in ICAS.
12. Thrombolysis and mechanical thrombectomy
Before 1995, stroke therapy consisted exclusively of supportive management and 
efforts to prevent recurrence [81]. In 1995, the National Institute of Neurological 
Disorders and Stroke reported that early intravenous thrombolysis using tissue plas-
minogen activator was more effective than placebo [81]. The use of Alteplase for 
acute ischemic strokes was approved by The Food and Drug Administration (FDA) 
in 1996 [82]. Thrombolytic therapy was initially offered to eligible patients up to 
4.5 hours from symptom onset. IV Alteplase was determined not to be as effective 
a therapy for patients with large vessel occlusions although it was proved to be an 
effective treatment. The concept of intraarterial pharmacologic thrombolysis was 
further expanded and solidified in 1999 with the completion of the Prolyse in Acute 
Cerebral Thromboembolism study [83]. Intravenous thrombolysis and intra-arterial 
thrombolysis received widespread acceptance and truly revolutionized the manage-
ment of acute stroke.
Mechanical thrombectomy has transformed our field, leading to an explosion 
in intervention for large vessel occlusion. Endovascular thrombectomy became the 
standard of care of the large vessel occlusion as a result of 5 randomized control 
trials (RCTs) in 2015 [84]. These 5 trials, MR CLEAN, ESCAPE, SWIFT PRIME, 
EXTEND-IA, and REVASCAT, extended the field of endovascular neurosurgery. 
These RCTs proved that patients who had improved functional outcome scores at 
90 days after thrombectomy with successful recanalization [84]. This was com-
pared with patients who received IV thrombolytic therapy alone or were unable to 
receive IV thrombolytic therapy. Improved functional outcomes were also demon-
strated by two additional landmark trials, DAWN and DEFUSE [85]. Endovascular 
thrombectomy for large vessel occlusion beyond the window of 3 to 4.5 hours has 
provided new treatment options and supportive data demonstrating improved 
functional outcome scores. Patients meeting eligibility criteria for mechanical 
thrombectomy had no additional risks in the extended window of 16 to 24 hours. 
The second generation of devices, including stent retrievers and aspiration cath-
eters, has demonstrated a significantly improved safety, revascularization, and 
patient outcome. Therefore, the criteria for mechanical thrombectomy, including 
time limit and physiological preconditions should be re-examined. Not only were 
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time limits extended, but also discussions on the ability to preserve additional tissue 
at risk, even in the setting of an established stroke, have made stroke interven-
tion a significant part of the foundation of endovascular practice. “Stroke center,” 
“mechanical thrombectomy ready,” and “comprehensive stroke center” designa-
tions have all been applied.
13. Tumor embolization and intra-arterial chemotherapy
Direct vascular access to brain tumors both benign and malignant has been 
exploited since the 1970s [86]. Preoperative embolization can facilitate resection 
and decrease intraoperative blood loss in the treatment of meningiomas. As with 
all endovascular strategies, keen understanding of the vascular anatomy is required 
to prevent unnecessary risk. Over the past few years, intra-arterial chemotherapy 
for more malignant tumors, such as gliomas, has had a resurgence. In future, the 
new neuro-pharmaceutical/chemotherapy/immunotherapy drugs, which could be 
delivered intra-arterially, will be developed [87].
14. Subdural hematoma embolization
Chronic subdural hematoma may be one of the most common neurological 
conditions requiring treatment in the future because of an aging population and 
the regular use of antiplatelet and anticoagulation medications. Chronic subdural 
hematoma has been managed with craniotomy and/or drainage both operatively and 
at the bedside. Embolization of the middle meningeal artery supply to the dura and 
subdural membranes as a renewed treatment of chronic subdural hematoma has 
been originally described by Japanese neurosurgeons almost 20 years ago [88]. The 
technique can be used as a rescue technique in patients who have undergone previous 
craniotomy as well as a primary treatment in patients with significant comorbidities. 
Particle embolization and liquid embolic agents have demonstrated excellent results 
in recent publications [89]. These encouraging results suggested the need for a large 
prospective randomized trial to investigate the true role of middle meningeal artery 
embolization as a stand-alone treatment for chronic subdural hematoma.
15. Resident and fellowship training
The expansion of endovascular techniques has led to a need to train neurosurgi-
cal residents in the application of endovascular therapies, just as they would learn 
newer techniques in spine or tumor neurosurgery. The Neurosurgery Residency 
Review Committee and American Board of Neurological Surgeons (ABNS) have 
correctly made regular adjustments in the area of endovascular case minimums for 
neurosurgery residents not only to include cerebral angiography, but now also to 
include more complex intervention experience, such as aneurysm coiling [90].
The future of endovascular neurosurgery would be inseparable from the future 
of neurosurgery. Residents interested in the vascular disease processes that affect 
the central nervous system must understand the application of neuroendovascular 
techniques and if they want to treat these pathologies must be adequately trained in 
their implementation. In Japan and China, most endovascular surgery is carried out 
by neurosurgeons who carry out cerebral and spinal cord angiography and interpret 
the images obtained. This experience not only increases their knowledge of vascular 
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We do not believe that the vascular neurosurgeon of the future must carry out 
both surgical and endovascular treatments. Precisely in order to reach the required 
excellence, there must be two figures, a vascular neurosurgeon who deals with the 
traditional surgical management knows the strengths and weaknesses of endo-
vascular treatment, and an endovascular neurosurgeon knows the strengths and 
weaknesses of surgical treatment. To remain at the forefront of evaluating, caring 
for, and treating patients with cerebrovascular disease, vascular neurosurgery must 
evolve toward a specialty, mastering the knife as well as the catheter. We think it is 
time for neurosurgeons to start training residents in endovascular neurosurgery in 
the same way we train neurosurgeons in every other neurosurgical discipline.
16. Conclusion
Endovascular neurosurgery provides management of neurovascular conditions 
encountered in clinical practice, such as aneurysms (with or without subarachnoid 
hemorrhage), AVMs, dural AVFs, and carotid disease. The success of endovascular 
thrombectomy for large vessel occlusion is now irrefutable, making it an accepted 
standard of care. Endovascular treatment of cerebral aneurysms is no longer limited 
to primary coiling but now includes options such as stent or balloon assistance, flow 
diversion, intrasaccular and bifurcation-specific devices. Balloons, liquid embolic 
agents, and distal access catheters have updated the treatment of arteriovenous mal-
formations and fistulae. The evolution of the neuroendovascular field has resulted 
in the development of program requirements for residency or fellowship education 
in endovascular neurosurgery.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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